SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-130007
Filing Date
2020-11-27
Accepted
2020-11-27 16:03:11
Documents
4
Effectiveness Date
2020-11-27

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2036932-2_s8.htm S-8 62362
2 EXHIBIT 5.1 tm2036932d2_ex5-1.htm EX-5.1 13241
3 EXHIBIT 23.1 tm2036932d2_ex23-1.htm EX-23.1 3517
4 GRAPHIC image_003.jpg GRAPHIC 3142
  Complete submission text file 0001104659-20-130007.txt   84603
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-251000 | Film No.: 201355336
SIC: 2834 Pharmaceutical Preparations